Consistent with the changes in CGRP levels in immunoblot analyses, the immunoreactivity of CGRP in the TNC in the CM group was significantly decreased by liraglutide treatment (Fig
Exercise: Physical activity involving the legs increases blood flow to the thigh, which can temporarily accelerate absorption
It mimics the action of glucagon-like peptide-1 (GLP-1), stimulating insulin release, suppressing glucagon secretion, and slowing gastric emptying
Subgroup analysis results Rights and permissions Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made